Showing results (71-80 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|September 27, 2025
Nivolumab plus gemcitabine-cisplatin for previously untreated unresectable or metastatic urothelial carcinoma: an Asian subgroup analysis from the global phase 3 CheckMate 901 trialYoshihiko Tomita, Ding-Wei Ye, Akifumi Fujii, et al.
Urologic Oncology|September 26, 2025
Association of interleukin-6 serum levels with local tumor stage and lymph node metastasis of urothelial carcinomaBenedikt Ebner, Judith Hirsch, Annkathrin Holz, et al.
Urologic Oncology|September 26, 2025
The association between prior pelvic radiotherapy for cancer and surgical outcomes in patients undergoing radical cystectomy for bladder cancer: An analysis of national surgical quality improvement program targeted cystectomy databaseRenil S Titus, Vatsala Mundra, Eusebio Luna Velasquez, et al.
Urologic Oncology|September 26, 2025
Utilization of intravesical chemotherapy following TURBT: A pre-implementation analysis of American College of Surgeon Commission on Cancer GU quality measuresOmri Nativ, Sabika Sadiq, Adam Williams, et al.
Urologic Oncology|May 25, 2024
Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancerMohamad Abou Chakra, Ian M McElree, Vignesh T Packiam, et al.
Urologic Oncology|December 19, 2020
A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancerXuan-Mei Piao, Ho Won Kang, Pildu Jeong, et al.
Urologic Oncology|December 23, 2020
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapyMaarten J van der Doelen, Niven Mehra, Inge M van Oort, et al.
Urologic Oncology|December 30, 2019
Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trialsQuoc-Dien Trinh, Fangxin Hong, Barbara Halpenny, et al.
Urologic Oncology|January 14, 2020
Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomySophie Knipper, Pierre I Karakiewicz, Alexander Heinze, et al.
Urologic Oncology|December 29, 2019
Reconsideration of pelvic floor muscle training to prevent and treat incontinence after radical prostatectomyPaul W Hodges, Ryan E Stafford, Leanne Hall, et al.
Pageof 487